Protocol for Psychopharmacologic Management of Behavioral Health Comorbidity in Adult Patients with Diabetes and Soft Tissue Infections in a Tertiary Care Hospital Setting

    loading  Checking for direct PDF access through Ovid

Abstract

GENERAL PURPOSE:

To provide information about the effect of psychiatric comorbidities on wound healing in patients with diabetes mellitus (DM).

TARGET AUDIENCE:

This continuing education activity is intended for physicians, physician assistants, nurse practitioners, and nurses with an interest in skin and wound care.

LEARNING OBJECTIVES/OUTCOMES:

After participating in this educational activity, the participant should be better able to:

LEARNING OBJECTIVES/OUTCOMES:

1. Discuss the connection between DM and the development of psychiatric comorbidities.

LEARNING OBJECTIVES/OUTCOMES:

2. Identify the drugs recommended in the treatment of these psychiatric comorbidities.

LEARNING OBJECTIVES/OUTCOMES:

3. List cautions and contraindications related to the drugs discussed.

In patients with diabetes mellitus type 2, psychiatric comorbidities such as depressive and anxiety disorders are 60% or more prevalent than in the general population. The severity of mental illness and the duration of diabetes have been shown to correlate with worsening glycemic control, thus impeding wound healing. A retrospective chart review was conducted in all patients with diabetes mellitus admitted to the wound service with prior or current psychiatric symptoms of anxiety, depression, or cognitive impairment. A psychopharmacologic protocol was developed based on the clinical data collected and treatment parameters used by the behavioral health consultation liaison service.

Related Topics

    loading  Loading Related Articles